Clinical Trial: Study on c-Met Targeted PET/CT Imaging in NSCLC

U.S., April 5 -- ClinicalTrials.gov registry received information related to the study (NCT06911697) titled 'Study on c-Met Targeted PET/CT Imaging in NSCLC' on March 28.

Brief Summary: The investigators developed a 18F labeled small molecule, 18F-TSPF, based on c-Met TKI, as a targeted molecular imaging agent for noninvasive and repeatable detecting c-Met activation status.

Study Start Date: Oct. 26, 2023

Study Type: INTERVENTIONAL

Condition: PET/CT Imaging NSCLC

Intervention: DIAGNOSTIC_TEST: 18F-TSPF PET/CT

Each subject receives interval imaging of 18F-TSPF PET/CT and 18F-FDG PET/CT, and further follow-up.

Recruitment Status: RECRUITING

Sponsor: Xilin Sun

Information provided by (Responsible Party): Xilin Sun, Harbin Medical U...